Search
Tyra Biosciences Inc
TYRAAdd to Watchlist
29.410USD
-2.530-7.92%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
1.75BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
16
analysts
Buy
Current Rating
51.455
Target Price
+61.10%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
562
Total
5
Median
6
Average
Company name
Ratings
Analysts
Tyra Biosciences Inc
TYRA
16
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
113
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Tyra Biosciences Inc's price target?
Analysts forecast that Tyra Biosciences Inc's price target is USD 31.00, with the highest forecast at USD 36.00 and the lowest forecast at USD 28.00.
How have Tyra Biosciences IncTYRA's recent earnings per share performed?
The market expectation was USD -0.64, while Tyra Biosciences IncTYRA's earnings per share (EPS) for the previous quarter was USD -2.01. EPS for the next quarter is expected at USD -0.64.
What is the analyst rating for Tyra Biosciences Inc?
Based on the ratings of Tyra Biosciences Inc's stock from 16 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.